gmp-verlag.de
 

Never ever a 483?

We can not promise that you will never get a 483
but we know that the GMP MANUAL includes all 
procedures and processes you need to be
GMP compliant.
 
Shopping cart
Your shopping cart is empty

Show shopping cart...
 
 
PDA Parenterals Conference

From 26-28 October, 2010 the PDA Parenterals Conference will be held in Berlin.

This outstanding event will cover the very important topics:

  • Future of Parenterals
  • Packaging and Impact on Quality
  • Manufacturing Flexibility and Control
  • Innovative Plants
  • Monitoring Technologies
  • Medical and Application Devices
  • Regulatory Trends

Don´t miss this interesting conference in Berlin, Germany.

Brochure of PDA Parenterals Conference 2010, October 26-28

 

News about GMP/cGMP

Herbal Medicinal Products

The EUs Comittee on Herbal Medicinal Products (HMPC) has established the ‘Community list of herbal substances , preparations and combinations thereof for use in traditional herbal medicinal products’. The list is being gradually developed through entries of structured information relating to individual herbal substances or preparations.

 

The list shall contain, for each herbal substance or preparation, the indication, the specified strength and the posology, the route of administration and any other information necessary for the safe use of the herbal substance or preparation used as an ingredient of a traditional medicinal product.

The Community list will provide a harmonised approach at EU level for providing the above-mentioned information on substance(s) or preparation(s) that constitute traditional herbal medicinal products. The list covers substances and preparations that have been in medicinal use for a sufficiently long time, and therefore considered not to be harmful under normal conditions of use.

When a draft entry for a given herbal substance or preparation has been produced by the Committee it is released for public consultation the Comitees website, usually for a period of 3 months. The draft entry is then finalised by the Committee from a scientific point of view, before being submitted for approval by the European Commission. Following this approval, the final version of the Community list entry is published.

The HMPC is also responsible for establishing Community herbal monographs with particular relevance for the registration as well as the authorisation of herbal medicinal products. For a further description of this work, and for published Community monographs, please refer to: Community monographs

In contrast to the Community herbal monographs, the Community list is legally binding to applicants and competent authorities in the Member States in so far as:

  • an applicant will not be required to provide evidence of the safe and traditional use of a medicinal product for which he seeks a traditional use registration if he demonstrates that the proposed product and related claims in the application comply with the information contained in the list;
  • competent authorities will not have the opportunity to require additional data to assess the safety and the traditional use of the product.
Outcome

If you are interessted in information concerning Herbal Medicinal Products, check the Comitees Website and take part in Public Consultations. An overview of ongoing HMPC assessment work in relation to establishing Community herbal monographs and/or enteries to the Community list can be found here.

Links

HMPC/ Website

HMPC/ Announcement

HMPC/ Community Monographs

HMPC/ Overview of assessment work

Comments
No comment have jet been written about this news